Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity

Qsymia™ (Vivus Inc, Mountain View, CA, USA), a combination of phentermine and delayed-release topiramate, has been available in the US since September 2012 for the treatment of obesity. Phentermine is an anorexigenic agent, which is approved for the short-term treatment of obesity, while topiramate...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jin Hee, Gadde, Kishore M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626409/
https://www.ncbi.nlm.nih.gov/pubmed/23630428
http://dx.doi.org/10.2147/DMSO.S43403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626409/
https://www.ncbi.nlm.nih.gov/pubmed/23630428
http://dx.doi.org/10.2147/DMSO.S43403

Ejemplares similares